CVE-2025-41384

Oct. 27, 2025, 1:19 p.m.

5.1
Medium

Description

Cross-Site Scripting (XSS) vulnerability reflected in SuiteCRM v7.14.1. This vulnerability allows an attacker to execute JavaScript code by modifying the HTTP Referer header to include an arbitrary domain with malicious JavaScript code at the end. The server will attempt to block the arbitrary domain but will allow the JavaScript code to execute.

Product(s) Impacted

Vendor Product Versions
Suitecrm
  • Suitecrm
  • 7.14.1

Weaknesses

Common security weaknesses mapped to this vulnerability.

CWE-79
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.

*CPE(s)

Affected systems and software identified for this CVE.

Type Vendor Product Version Update Edition Language Software Edition Target Software Target Hardware Other Information
a suitecrm suitecrm 7.14.1 / / / / / / /

CVSS Score

5.1 / 10

CVSS Data - 4.0

  • Attack Vector: NETWORK
  • Attack Complexity: LOW
  • Attack Requirements: NONE
  • Privileges Required: NONE
  • User Interaction: ACTIVE
  • Scope:
  • Confidentiality Impact: NONE
  • Integrity Impact: NONE
  • Availability Impact: NONE
  • Exploit Maturity: NOT_DEFINED
  • CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

    View Vector String

Timeline

Published: Oct. 27, 2025, 1:15 p.m.
Last Modified: Oct. 27, 2025, 1:19 p.m.

Status : Undergoing Analysis

CVE has been marked for Analysis. Normally once in this state the CVE will be analyzed by NVD staff within 24 hours.

More info

Source

cve-coordination@incibe.es

*Disclaimer: Some vulnerabilities do not have an associated CPE. To enhance the data, we use AI to infer CPEs based on CVE details. This is an automated process and might not always be accurate.